Floatz logo

CANNABIVAROL, .DELTA.9-TETRAHYDRO-

Hyperglycemia

Medical Life Care Planners, LLCSmall moleculeEarly Phase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Hyperglycemia cohort.

Asset / SponsorPhaseRating
Metformin
The First Affiliated Hospital of Xiamen University
Phase 4BBB
Olanzapine
Washington University School of Medicine
Phase 4BB
Exenatide
Saint Luke's Health System
Phase 4BB
Sitagliptin
Dawn Smiley MD
Phase 4BB
Capecitabine
Brigham and Women's Hospital
Phase 4BB

View all 34 →

Same molecule, other indications

CANNABIVAROL, .DELTA.9-TETRAHYDRO- is also rated in:

HypercholesterolemiaDormant
CC
Indicative ·
43 / 100
View asset →
morbid obesityDormant
CC
Indicative ·
41 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →